These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30645642)

  • 1. LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia.
    Kim J; Pajarillo E; Rizor A; Son DS; Lee J; Aschner M; Lee E
    PLoS One; 2019; 14(1):e0210248. PubMed ID: 30645642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction.
    Pajarillo E; Kim S; Digman A; Dutton M; Son DS; Aschner M; Lee E
    J Biol Chem; 2023 Jul; 299(7):104879. PubMed ID: 37269951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy.
    Chen J; Su P; Luo W; Chen J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):171-177. PubMed ID: 29408508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.
    Puccini JM; Marker DF; Fitzgerald T; Barbieri J; Kim CS; Miller-Rhodes P; Lu SM; Dewhurst S; Gelbard HA
    J Neurosci; 2015 Apr; 35(13):5271-83. PubMed ID: 25834052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils.
    Russo I; Kaganovich A; Ding J; Landeck N; Mamais A; Varanita T; Biosa A; Tessari I; Bubacco L; Greggio E; Cookson MR
    Neurobiol Dis; 2019 Sep; 129():67-78. PubMed ID: 31102768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microglial LRRK2 in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction.
    Pajarillo E; Kim SH; Digman A; Dutton M; Son DS; Aschner M; Lee E
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia.
    Maekawa T; Sasaoka T; Azuma S; Ichikawa T; Melrose HL; Farrer MJ; Obata F
    BMC Neurosci; 2016 Nov; 17(1):77. PubMed ID: 27903237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 and WAVE2 regulate microglial-transition through distinct morphological phenotypes to induce neurotoxicity in a novel two-hit in vitro model of neurodegeneration.
    Fenner BM; Fenner ME; Prowse N; Hayley SP
    J Cell Physiol; 2022 Jan; 237(1):1013-1032. PubMed ID: 34543438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells.
    Russo I; Berti G; Plotegher N; Bernardo G; Filograna R; Bubacco L; Greggio E
    J Neuroinflammation; 2015 Dec; 12():230. PubMed ID: 26646749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin Attenuates Manganese-Induced Neuroinflammation by Alleviating Oxidative Stress through Regulation of Apoptosis, iNOS/NF-κB and HO-1/Nrf2 Pathways.
    Bahar E; Kim JY; Yoon H
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity.
    Roth JA; Eichhorn M
    Neurotoxicology; 2013 Jul; 37():100-7. PubMed ID: 23628791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.
    Ma B; Xu L; Pan X; Sun L; Ding J; Xie C; Koliatsos VE; Cai H
    Hum Mol Genet; 2016 Aug; 25(16):3515-3523. PubMed ID: 27378696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration.
    Dwyer Z; Rudyk C; Thompson A; Farmer K; Fenner B; Fortin T; Derksen A; Sun H; Hayley S;
    Neurobiol Aging; 2020 Jul; 91():45-55. PubMed ID: 32247534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.
    Gillardon F; Schmid R; Draheim H
    Neuroscience; 2012 Apr; 208():41-8. PubMed ID: 22342962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein.
    Marker DF; Puccini JM; Mockus TE; Barbieri J; Lu SM; Gelbard HA
    J Neuroinflammation; 2012 Nov; 9():261. PubMed ID: 23190742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.
    Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
    Neurochem Res; 2016 Oct; 41(10):2675-2692. PubMed ID: 27394417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to
    Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO
    Elife; 2020 Feb; 9():. PubMed ID: 32057291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity.
    Ho DH; Seol W; Eun JH; Son IH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1088-1094. PubMed ID: 27914807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2.
    Nazish I; Mamais A; Mallach A; Bettencourt C; Kaganovich A; Warner T; Hardy J; Lewis PA; Pocock J; Cookson MR; Bandopadhyay R
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models.
    Li T; Yang D; Zhong S; Thomas JM; Xue F; Liu J; Kong L; Voulalas P; Hassan HE; Park JS; MacKerell AD; Smith WW
    Hum Mol Genet; 2014 Dec; 23(23):6212-22. PubMed ID: 24993787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.